Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating often fatal, rare diseases.
11.18.2013 - Aegerion Pharmaceuticals Presents Data from Phase 3 Extension Study of JUXTAPID(TM) (lomitapide) Capsules in Homozygous Familial Hypercholesterolemia at AHA Scientific Sessions
10.30.2013 - Aegerion Pharmaceuticals Announces Third-Quarter 2013 Financial Results
9.9.2013 - Aegerion Pharmaceuticals' Lomitapide Receives Orphan Drug Designation in Japan for the Treatment of Homozygous Familial Hypercholesterolemia
2012 Annual Report
© 2012 Aegerion Pharmaceuticals, Inc. All rights reserved. AEGR/Global/167 06-13